Foot Botox

In short: Foot botox is an intradermal injection of botulinum toxin to treat excessive sweating on the soles of the feet (plantar hyperhidrosis). It is a procedure where the effect begins in 5-7 days and lasts for 4-6 months, and pain management (nerve block or topical anesthesia) is very important. Its effectiveness is high, side effects are minimal.

Description

Foot botox is applied for the treatment of plantar hyperhidrosis (excessive sweating on the soles of the feet). Plantar hyperhidrosis, which is in the primary focal hyperhidrosis (ICD-10 R61.01 — foot) type, usually begins in adolescence or young adulthood, and is seen in patients who experience excessive sweating throughout the day or not related to stress. The sole of the foot is an area of ​​high density of eccrine sweat glands—600-700 glands per cm² (axilla ~200/cm²). Botulinum toxin type A reduces sweat secretion by 76-85% by blocking the release of acetylcholine in the nerve endings of these glands. The procedure requires topographic marking (Minor iodine-starch test), anesthesia management and precise injection technique.

Regional Anatomy — Sole of the Foot

Skin and Dermal Structure: The skin on the sole of the foot is mostly thick (1.5-2 mm epidermis + dermis) and has a narrow range of motion (as stable as the palmar dermis). The stratum corneum (thick outer layer) provides mechanical strength; this makes intradermal injection thick but feasible.

Sweat Glands — Eccrine Density: The sole of the foot (plantar area) has a high concentration of eccrine sweat glands—specifically:

• Medial plantar: Greater toe edge and medial metatarsal heads—high gland density
• Lateral plantar: Small toes and lateral foot edge — medium density
• Central plantar: Arch (foot arch) — variable density
• Heel (heel): In the calcaneus area, high pressure area — moderate sweat secretion

Botulinum toxin should target all these areas—injection range per area 1.5-2 cm, geographic coverage 80-90% (Minor test marked hyper-hidrotic area).

Vascular Anatomy — Injection Risks:

• Medial plantar artery: On the medial foot side, the branch of the posterior tibial artery; Be careful with superficial injection (risk of vascular impact is low but possible)
• Lateral plantar artery: On the lateral foot side; similar risk
• Dorsalis pedis artery: Dorsal foot (above the injection, not plantar — risk is minimal with plantar injection)

Nerve Anatomy—Critical for Pain Management:

• Posterior Tibial Nerve: The back of the medial talus is divided into medial and lateral plantar branches; both provide plantar dermatome innervation—RING BLOCK target
• Sural Nerve: The lateral foot innervates the lateral heel and lateral foot edge from the posterior leg — lateral component of the RING BLOK
• Superficial peroneal (fibular) nerve: Dorsum pedis innervation — low risk during plantar procedure

Pain management is provided by ring block anesthesia (posterior tibial + sural) or topical EMLA + mechanical desensitization (vibration, ice pack) — Pain control is the key to plantar botox success.

Foot Biomechanics and Sweating Pattern: The sole of the foot is the area of ​​maximum pressure during body weight distribution — stratum corneum thickness (fairness), sebum secretion is low, sweat density is high. Dynamic activity (walking, running) pressure increase → sweat production stimulation. Idiopathic (unprovoked) plantar hyperhidrosis shows constant sweat production regardless of central nervous system stimulation (stress, heat).

Plantar Hyperhidrosis—Functional Impairment, Not Aging

Foot botox is not a treatment for "signs of aging" — on the contrary, It is a medical conditioning (primary focal hyperhidrosis) treatment. Plantar hyperhidrosis is not associated with aging; People of any age can be affected. Pathological results:

• Psychosocial impact (DLQI high): The person avoids social activities due to constantly wet feet (anxiety about taking off shoes, limited shoe selection, work performance may be affected)
• Skin infections: A humid environment is suitable for the growth of fungi (Trichophyton, Candida) or bacteria (staphylococcus, streptococcus).
• Dermatitis and eczema: Makserasi (skin softening), friction dermatitis
• Shoe deterioration: Its only source deteriorates quickly (moisture + salt), costly

Treatment Protocol

Stage 1: Evaluation and Minor Iodine-Starch Test

The patient is asked about the severity of hyperhidrosis (HDSS - Hyperhidrosis Disease Severity Scale 1-4). HDSS ≥3 → botox indication. Topographic mapping:

1. Feet are cleaned and completely dried
2. Minor iodine-starch test: iodine solution (Lugol 2%, 100-200 mL) is applied to the sole of the foot; dried for 2 minutes
3. Corn starch powder is sprinkled — areas with sweat turn dark blue (iodine-starch complex)
4. Hyperhidrotic area is marked and photographed — injection limits are determined
5. Gravimetric measurement (optional): 1 minute filter paper, pressed in hyperhidrotic area, weighed (100+ mg sweat to baseline)

Stage 2: Anesthesia—Critical Pain Management

Plantar botox is one of the most painful of all aesthetic injections. Reasons: (1) the sole of the foot is very sensitive sensory (low threshold for mechanical stimulation), (2) the tight skin structure resists the needle, (3) a large number of injection points (40-50). Anesthesia options:

• Ring Block Anesthesia (GOLD STANDARD): Posterior tibial + sural nerve block, 1% lidocaine 20-30 mL + 1:100k epinephrine. Technique: injection from the medial ankle (posterior tibial) and lateral ankle (sural), the entire plantar surface of the foot remains numb (10-15 minutes before). Advantage: complete pain relief, patients feel comfortable. Disadvantage: requires technique, risk of vascular puncture (<0.1%), operator experience.
• Topical EMLA Cream + Vibration/Ice: EMLA (eutectic mixture of lidocaine-prilocaine) cream 4-5 grams, plastic wrap cover, 45-60 minutes. Additional: vibration during injection (mechanical gate control analgesia) + ice pack (cryotherapy). Advantage: non-invasive, no blocks required. Disadvantage: not complete pain relief (moderate discomfort is still possible), time consuming.
• Combination: Ring block + topical EMLA → maximal comfort (residual anesthesia of the ring, topical supplement)

Step 3: Botulinum Toxin Preparation

• Product: Botulinum Toxin A (Botox® 100U vial, Dysport® 500U, or Xeomin® 100U)
• Dose: Bilateral 100U Botox per foot (total 200U bilateral); Dysport equivalent ~250-300U (due to different protein complex)
• Dilution: Botox 100U diluted in 3-4 mL of sterile saline → 25-33 U/mL (0.1 mL = 2.5-3.3U). Concentration: suitable for injection pressure and volume control
• Preparation time: It is diluted immediately before injection; stability is 24 hours

Stage 4: Injection Technique — Intradermal Grid

1. Needle selection: 27-30 G needle, insulin syringe (0.1 mL precision) is preferred (e.g., 1 mL BD syringe, 30G insulin needle)
2. Injection depth: intradermal (intradermis, subcutaneous EUPTI) — needle at 45° angle, very slightly 2-3 mm penetration → white wheal (injection scar) is formed
3. Grid Pattern: Hyperhidrotic area marked by minor test:
   • Medial plantar: thumb+2. finger base, metatarsal heads → 2-3U Botox to 12-15 points
   • Central plantar: 3-4-5 metatarsal heads → 12-15 points
   • Lateral plantar: 5th finger, lateral arch → 8-10 points
   • Heel: heel medial/lateral → 8-10 points
   • Total: 40-50 injection points, bilateral 100U/foot ≈ 2-2.5U/point
4. Injection order: Movement from distal (toe base) to proximal (heel), pressure with stable hand position
5. Post-injection: Short walk around (to 15 minutes) — minimal hematogenic spread of the toxin (as local effect is intended), but some diffusion natural → slight infiltration into adjacent compartments

Products and Devices Used

Botulinum Toxin Formulations:

• Botox (onabotulinumtoxinA) — Allergan: FDA approved for plantar hyperhidrosis (2004). Dose: 100U/foot intradermal (plantar area). Efficacy: 76-85% sweat reduction, onset 5-7 days, peak 2-3 weeks, effect 4-6 months.
• Dysport (abobotulinumtoxinA) — Galderma: More diffuse diffusion (protein complex different). Dose: ~2.5-3× more (250-300U plantar hyperhidrosis), but similar efficacy. Advantage: wide spread; Disadvantage: more susceptible to neighboring muscle influence (but selective to plantar sweat glands).
• Xeomin (incobotulinumtoxinA) — Merz: Protein "naked" (no complex), protein free. Dosage: Botox equivalent. Human immunology may reduce exposure (low risk of resistance). It is less used in Türkiye, but it is an option.

Anesthesia Products:

• Lidocaine 1% + epinephrine 1:100k (ring block)
• EMLA cream (eutectic lidocaine + prilocaine)
• Vibration device (optional, helpful in topical anesthesia)
• Ice pack (cryoanesthesia)

Additional Devices:

• Minor iodine-starch test kit (iodine solution + starch)
• Photo documentation (baseline + post-procedure)
• Filter paper (optional gravimetric measurement)

Application Details

Preparation Before You Start:

1. Washes and dries the feet in the morning before the patient (skin cleansing)
2. Anesthesia is started 30-45 minutes before the injection session (10-15 minutes before for ring block; 45-60 minutes for EMLA).
3. A minor test is performed on the patient, hyperhidrotic areas are marked, photographs are taken.
4. Botulinum toxin is prepared and filled into syringes

Application Steps:

1. Recovery from Anesthesia: After the ring block, it is confirmed that the entire plantar surface of the foot is numb with a pin-prick test. If it is topical EMLA, the patient is told that mild pain can be expected.
2. Skin Antisepsis: Chlorhexidine 0.5% or povidone-iodine 10% solution is applied to the sole of the foot and dried for 30 seconds.
3. Injection Start: The 27-30G needle is advanced in a grid pattern starting from the distal end of the marked hyperhidrotic area. Each spot produces 0.1 mL (2-3U), intradermal white wheal.
4. Time and Attention: 40-50 point injections take ~15-20 minutes. The operator balances speed and precision — too fast = post-refraction touch; too slow = sick pain, anxiety.
5. To finish: Do not gently massage the foot after injection (risk of increased diffusion of the toxin); hemostasis based on observation only (pressure if required).

Patient Instructions (Post-Procedure):

• Lying down for the first 4 hours (localization of toxin by gravity)
• Avoiding intense exercise, sauna, hot baths for the first 48 hours (increased risk of hematogenic spread)
• Ibuprofen (aspirin → risk of bleeding) if painkillers are needed
• Ecchymosis/swelling for 5-7 days is normal, not alarming
• Keeping feet clean and dry at all times (avoiding infection)

Healing Process and Downtime

Chart:

Foot botox — Recovery timeline

period	Duration	Expected Situation
Immediately after injection	0-1 hour	Mild swelling, redness, white wheals; pain is minimal (anesthesia is still active)
first day	0-24 hours	Anesthesia relief → mild to moderate pain possible (ibuprofen is sufficient); onset of ecchymosis
Day 2-3	2-3 days	Maximal swelling (edema peak); ecchymosis purple-yellow; pain is minimal in most patients
Day 4-7	4-7 days	Reduced bloating; ecchymosis fading (purple → yellow); feet "begin to dry slowly"
Week 2	14 days	The swelling and ecchymosis have almost resolved; early signs of decreased sweating (most patients do not report, but measurement shows improvement)
Week 3-4	3-4 weeks	Significant reduction in sweating; patients report reduced sock wetting, reduced odor, fungus improvement
Week 5-6	5-6 weeks	Beginning of decreased maximal sweating; peak activity (started 2-3 weeks, now stable)
Month 2-6	2-6 months	Sweating control is stable; impact plateau
After month 4-6	4-6 months+	The effect begins to wane; muscle function gradually returns; reinjection required (between months 4-6)

Downtime Summary: Minimal downtime. Patients can return to normal activities (light walking, avoiding massage) the same day after injection. 1 week of sports, intense exercise is recommended (relative). No social downtime — ecchymosis is not visible because the foot is closed (inside the shoe).

Contraindications

• Pregnancy and Breastfeeding: Botulinum toxin FDA category C; insufficient safety data
• Neuromuscular Disease: Myasthenia gravis, Lambert-Eaton syndrome, ALS — BoNT is dangerous (neuromuscular junction is already weak)
• Allergy to Botulinum Toxin: Allergy to additional proteins (very rare)
• Active Foot Infection: Fungical or bacterial infection — increased diffusion of the toxin + risk of dissemination of infection
• Heavy Anticoagulation (INR >3): Risk of ecchymosis and bleeding; Can be done with informed consent but caution required
• Psychiatric Disease Requiring Sedation: Anesthesia comorbidity

Risks and Side Effects

Common (Mild, Transient):

• Pain at the Injection Site: Mild to moderate pain from intradermal injection, resolving within 24-48 hours (ibuprofen, analgesic adequate)
• Ecchymosis (Hematoma): Due to needle traumas, it takes 5-7 days; 2-3 weeks for those using anticoagulants
• Bloating (Edema): Injection trauma and botulinum toxin inflammation, peak for 2-3 days, then disappear
• Mild Paresthesia (Drowsiness): Post-injection infrared sensory fiber trauma resolves within 1-2 days

Rare (Moderate-Severe):

• Vascular Occlusion (Vascular Thrombosis): Very rare — from medial/lateral plantar artery injection trauma. Symptoms: disproportionate pain, finger discoloration, cyanosis. Management: URGENT dermatology consult, elevate, oxygen, optional hyperbaric oxygen (HBO).
• Eye Infection (Cellulitis): From bacterial inoculation (rare), symptoms access, feber, skin temperature. Management: oral/IV antibiotics
• Compensatory Sweating: Increased trunk/back, upper extremity sweating after plantar sweating decreases — unsystematic, individual, usually mild. Psychological: "I hit my pain where I scratched" effect. Management: patient education, waiting (adapted)

Very Rare/Serious:

• Anaphylaxis (to botulinum toxin); minimum number of reported incidents
• Systemic toxin diffusion (not seen at aesthetic doses)
• Permanent neurological damage (rare, no reports)

Results and Duration of Effect

Onset and Peak Effect:

• 5-7 days: First effect — patients notice slight reduction in sweating
• 2-3 weeks: Noticeable effect — sock wetting is significantly reduced
• 4-6 weeks: Maximal effect — sweat production 76-85% below baseline

Effect Duration: 4-6 months (shorter than axilla 6-9 months). The foot is the area where the metabolic rate is high; botulinum toxin faster degradation. Repeatable injections, cumulative effect (muscle atrophy + change in eating habits) → long-term decrease in sweating may become permanent.

Maintenance Plan: Reinjection is required at months 4-6; Patients usually report "sweating returns" by the end of month 4. Repeated injections (every 6-12 months) may provide long-term cumulative benefit.

Price and Package Structures in Türkiye

Foot botox pricing varies by dose (100U/foot) and margin — average in 2026 Turkey:

• Single Session (Bilateral 200U): 15,000 TL - 30,000 TL (depending on operator experience, clinic location)
• Package Pricing: Optional — reinjection in month 4, discount (e.g. 40,000 TL for 3 sessions = 13,300 TL per session)
• Brand Difference: Botox (original Allergan) > Dysport (Galderma) ≈ topical drugs (cheaper) — but minimal difference in effectiveness

Region-Specific Measures (Before/After)

Before Injection (Pre-Procedure):

• NSAID (ibuprofen, naproxen) avoidance for 1 week — risk of bleeding/ecchymosis (but minor)
• 48-hour avoidance of alcohol—bleeding, edema plus
• Clean feet, dry them (infection avoidance)
• Choose comfortable shoes (bloating possible after injection)
• Psychiatric preparation: anticipation of pain (anesthesia will be provided) minimizes the problem

After Injection (Post-Procedure):

• First 4 Hours: Don't go to bed; elevation at heart level (edema reduction)
• First 48 Hours: Avoidance of intense exercise, sauna, hot bath, massage (risk of diffusion of toxin + increase in edema)
• First 1 Week: Minimizing strenuous activities (running, football, yoga) — reduce landing force
• Ongoing Maintenance: Keeping feet clean, dry every day (fungal avoidance). SPF 30+ sunscreen (UV protection if foot dorsum is open). Avoiding humid environment (dry well with towel).
• Pain Management: Ibuprofen 400-600 mg Q6H if necessary (first 3 days)

Op. Dr. Hamza Gemici Comment

Plantar hyperhidrosis is an important issue in medical dermatology—pain control and psychological relief form the basis of patient satisfaction. Pain management (ring block anesthesia) is very important; Topical anesthesia is insufficient. Botox has proven effectiveness (76-85% sweat reduction) and is FDA approved (2004). Technical precision and Minor test marking → determine success. If compensatory sweating is rare and mild, patient education (sock wetting, fungus avoidance, psychological relaxation) is the metric of success. Plantar hyperhidrosis treatment is a "quality of life" problem solution, not an "aesthetic in old age" problem solution — that's why every patient's success story is valuable.

Related Terms

• Axillary Hyperhidrosis (Armpit Hyperhidrosis)
• Botox (General)
• Botulinum Toxin Type A
• Masseter Botox
• Forehead Botox
• Dysport
• Xeomin
• ecchymosis

Frequently Asked Questions

Q1. Isn't foot botox painful at all?

A: There is pain — 40-50 injection points, the intradermal technique is quite painful. However, ring block anesthesia (posterior tibial + sural nerve block) causes almost no pain; topical EMLA + vibration = mild-moderate discomfort. Pain control is critical to the success of the procedure—good anesthesia, happy patient.

Q2. Does foot botox work?

A: Yes, 76-85% sweat production reduction confirmed by Vanstreenkiste 2004 study and FDA approval (2004). The HDSS scale drops from 3-4 to 1-2. Patients report reduced sock wetting, odor, and reduced risk of fungal infections.

Q3. Is there a lot of pain?

A: Mild-moderate pain at the time of injection (minimal if anesthesia is provided); Mild pain/swelling for 24-48 hours afterwards (ibuprofen is sufficient). Do not expect severe pain.

Q4. Is there ecchymosis?

A: It is possible, mild-moderate ecchymosis in 30-50% of patients (5-7 days). It's not visible because it's inside the shoe. More severe in those using anticoagulants (2-3 weeks).

Q5. How long does it last?

A: 4-6 months (shorter than axilla — difference in metabolism). Repeated injections can provide cumulative effect and permanent improvement.

Q6. Is there any feedback?

A: Yes, sweating gradually returns in months 4-6. Reinjection required (maintenance between months 4-6).

Q7. Does the risk of fungal infection decrease?

A: Yes, significantly. A humid environment is suitable for fungi; decreased sweating → drier feet → risk of fungus decreases. Patients often report "fungal loss."

Q8. What is compensatory sweating?

A: After foot sweating decreases, slight increase in sweating in another part of the body (back, trunk, scalp) — rare, most patients do not experience it. Body sweating still does not cause as much discomfort as wet feet.

Q9. Can those who have axillary botox also receive botox on the feet?

A: Yes, no problem — different areas, different dose and time. The combination increases the severity of both axillary and plantar hyperhidrosis. Protocol: same time or separate sessions (flexibility).

Q10. Can men get foot botox?

A: Absolutely, plantar hyperhidrosis is not gender-specific. Men (especially athletes and those who wear heavy shoes) often prefer it. The procedure is the same; the result is equal.

Resources

Last update: April 22, 2026 · Medical editor: Op. Dr. Hamza Gemici